Meeting your needs, today and in the future
Eramol provides bespoke clinical trial solutions to meet a diverse array of its clients’ needs.
Evolving to meet market needs
We are a responsive company and fully understand that requirements and needs change quickly in an ever-evolving environment. We do everything to address this fluidity, with an approach that constantly stays one step ahead of the market.
Founded by experts
Eramol was co-founded by two Qualified Persons with significant experience in managing clinical trial manufacturing projects in both commercial and non-commercial organisations. Eric Che and Peter Mollison established Eramol together, building upon their expertise and industry knowledge, with the shared insight to provide a critical response to companies undertaking clinical trials.
The company is privately owned. As a private equity-free company, Eramol is able to act in the best interests of the Company and its Clients, with a focus on service, delivery and innovation.
Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements.
Eramol has developed a profound customer process that aims to deliver complete satisfaction to our clients at every stage.
Eramol is an authorised organisation across many strategic areas of the business. Accreditations relate to MHRA, HPRA, MHRA GDP and WDA(v). We work with all relevant bodies to ensure the very latest accreditations in line with ongoing, continuous developments in the industry.